# Gmo Testing Market

> GMO Testing Market Size, Share, Industry Trend & Analysis Research Report By Technology (Polymerase Chain Reaction (PCR), Immunoassay (ELISA, Lateral Flow), Next-Generation Sequencing, Biosensor-based Rapid Tests), By Crop Type (Corn, Soybean, Cotton, Canola, Potato, Wheat, Rice, Others), By Application (Processed Food, Animal Feed, Seed Testing, Others), By Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Forecast to 2035.

- **Forecast Period:** 2026-2035
- **CAGR:** 5.5%
- **2025:** USD 4.06 Billion
- **2035:** USD 6.91 Billion
- **Key Players:** Eurofins Scientific SE, SGS SA, Intertek Group plc, Bureau Veritas SA, ALS Limited, Mérieux NutriSciences Corp., Cotecna Group, Neogen Corporation

**Report ID:** MRFR/FnB/31039-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** October 28, 2026

**URL:** https://www.marketresearchfuture.com/reports/gmo-testing-market-32843

---

## Market Summary

## GMO Testing Market Summary

The global GMO testing market was valued at USD 4.06 Billion in 2025 and is projected to reach USD 4.27 Billion in 2026, rising to USD 6.91 Billion by 2035 at a CAGR of 5.5% over 2026–2035. Two policy anchors explain most of the demand. The United States made its National Bioengineered Food Disclosure Standard mandatory in January 2022 [4], and genetically engineered varieties already account for 96% of US soybean acreage [1]. Every bushel moving from those fields into a labeled or import-controlled channel creates a sample.

Laboratory technology is changing underneath that demand. Protein strip tests and conventional endpoint PCR are giving way to real-time quantitative PCR, multiplex panels, digital PCR and sequencing-based characterization. Europe's reference laboratory network now validates event-specific methods as a condition of authorization [13], and the European Commission's 2023 proposal on new genomic techniques has pushed laboratories to invest in detection approaches for edits that leave no foreign DNA. Scale matters too: Eurofins Scientific reported EUR 5.142 billion in revenue for the first nine months of 2024 [19], a measure of how much capital the leaders can direct into automation.

Europe leads with a 34.5% share of the GMO testing market, reflecting the world's strictest labeling threshold. Middle East and Africa is the fastest-growing region at a 6.9% CAGR, while North America ranks second at USD 1.18 Billion. Over the next decade, growth will track the spread of biotech approvals into new countries and the regulatory treatment of gene-edited crops.

## Key Report Takeaways

### • By Technology

- Polymerase Chain Reaction (PCR) held a 58.9% share of the GMO testing market in 2025, supported by validated event-specific methods accepted by regulators worldwide
- Next-Generation Sequencing is set to expand at a 6.7% CAGR as regulators request full molecular characterization in dossiers
- Biosensor-based Rapid Tests generated USD 0.31 Billion in 2025, driven by on-site screening at elevators and processing plants

### • By Crop Type

- Corn accounted for a 31.8% share in 2025, reflecting the volume of stacked-trait hybrids in global trade
- Canola is the fastest-growing crop segment at a 7.3% CAGR, helped by acreage gains in the United States
- Soybean testing was worth USD 1.20 Billion in 2025

### • By Application

- Processed Food led the GMO testing market with a 48.3% share, as labeling rules require ingredient-level verification
- Seed Testing is projected to grow at a 6.6% CAGR on the back of trait-development pipelines

### • By Region

- Europe held a 34.5% share in 2025, anchored by the 0.9% labeling threshold
- Middle East and Africa is forecast to grow at a 6.9% CAGR as new countries approve biotech crops
- North America reached USD 1.18 Billion in 2025

## Market Size and Forecast (2021–2035)

Historical values for the GMO testing market were built from laboratory revenue disclosures, regulatory sample volumes, crop acreage and trade flows, then validated through interviews with laboratory directors, seed company regulatory teams and food manufacturers. Forecast values apply a calibrated growth path that reflects labeling enforcement, biotech approvals and technology replacement cycles.

## Market Drivers

## Driver Impact Analysis

| Driver | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| Mandatory labeling and traceability rules | +1.3% | Europe, North America | Long-term (≥4 yr) | [2][3][4] |
| Expansion of biotech crop acreage | +1.1% | Americas, Asia-Pacific | Medium-term (2–4 yr) | [1][5] |
| Growth of non-GMO and organic claims | +0.9% | North America, Europe | Medium-term (2–4 yr) | [7] |
| Import certification requirements in Asia | +0.7% | Asia-Pacific | Short-term (≤2 yr) | [8][9] |
| Biotech approvals in new markets | +0.6% | Middle East and Africa, Asia-Pacific | Medium-term (2–4 yr) | [10][23] |
| Seed development and stacked-trait pipelines | +0.5% | Global | Long-term (≥4 yr) | [13][14] |

### Mandatory Labeling and Traceability Rules

When permitted genetically modified material makes up more than 0.9% of an ingredient, Europe's Regulation (EC) No 1829/2003 and Regulation (EC) No 1830/2003 mandate labeling and require operators to keep traceability records for five years [2][3]. With a 5% inadvertent-presence criterion, the National Bioengineered Food Disclosure Standard went into effect in the US on January 1, 2022 [4]. Both regimes force producers to switch from supplier statements to lot-level quantitative data, making compliance a periodic laboratory volume.

### Expansion of Biotech Crop Acreage

In 2019, biotech crops were grown on 190.4 million hectares in 29 nations [5], and in 2024, 96% of US soybean land was genetically modified [1]. Event-specific identification is required at the origin, transshipment, and destination of bulk cargoes departing certain industrial zones for controlled import markets. As a result, sample counts at grain elevators, crushers, and port laboratories rise in proportion to export tonnage when acreage increases.

### Growth of Non-GMO and Organic Claims

The Non-GMO Project lists more than 60,000 verified products [7], and each verified ingredient requires periodic quantitative screening against action thresholds. Retail private labels have extended non-GMO verification to [dairy](https://www.marketresearchfuture.com/reports/dairy-market-11483), eggs and meat, where feed inputs rather than the finished food must be tested. That shift moves demand upstream into feed mills and meal suppliers, adding volume that did not exist when claims covered mainly packaged snacks.

### Import Certification Requirements in Asia

India's food regulator has required a non-GM origin cum GM-free certificate for 24 imported food crops since March 2021 [8]. China's agriculture ministry approved new GM corn and soybean varieties for domestic planting in October 2023 [9], which sharpens its need to separate approved from unapproved events at the border. Exporters to both countries now commission pre-shipment certificates, and laboratories in Singapore, Thailand and India are adding capacity to handle the submissions.

### Biotech Approvals in New Markets

Nigeria's biosafety regulator approved TELA insect-resistant maize in January 2024 [10], and Kenya lifted its decade-long ban on GM crops in October 2022 [23]. Each approval obliges national authorities to build reference laboratories, event libraries and border inspection protocols. International laboratory groups usually supply the initial capacity through partnerships, giving these markets growth rates well above the global average.

### Seed Development and Stacked-Trait Pipelines

Seed developers increasingly combine three to five traits in a single hybrid, and every stack must be characterized before authorization. Europe will not authorize an event until its reference laboratory has validated an event-specific detection method [13], and those methods must meet Codex performance criteria for specificity and limit of detection [14]. Pipelines focused on drought tolerance and disease resistance add dossiers each year, sustaining demand for seed purity and characterization work.

## Restraints

## Restraints Impact Analysis

| Restraint | ~% Impact on CAGR | Geographic Relevance | Impact Timeline | Ref |
| --- | --- | --- | --- | --- |
| High capital cost of advanced platforms | -0.6% | South America, Middle East and Africa, Asia-Pacific | Medium-term (2–4 yr) | [5] |
| Non-harmonized thresholds and approvals | -0.5% | Global | Long-term (≥4 yr) | [14][15] |
| Detection gaps for gene-edited products | -0.4% | Europe | Long-term (≥4 yr) | [20] |
| Limited accredited laboratory capacity | -0.4% | Middle East and Africa, South America | Medium-term (2–4 yr) | [10] |
| Deregulation of precision-bred crops | -0.3% | United Kingdom, North America | Long-term (≥4 yr) | [16] |

### High Capital Cost of Advanced Platforms

Before a laboratory processes a single sample, six-figure investments are needed for sequencing equipment, digital PCR systems, and automated extraction lines. Smaller national laboratories that grow transgenic crops in lower-income nations [5] frequently rely on qualitative screening and postpone procurement. This hinders the transition to higher-value quantitative labor and maintains low prices per sample in certain markets.

### Non-Harmonized Thresholds and Approvals

The 173 parties to the Cartagena Protocol use different approval lists, with thresholds ranging from 0.9% in Europe to 5% in the US [15]. Exporters are forced to operate several panels since an event that is authorized in one jurisdiction could not be in another. In addition to adding testing, this increases the expense of disputes and deters smaller dealers from using regulated channels.

### Detection Gaps for Gene-Edited Products

Plants produced through targeted mutagenesis can carry changes indistinguishable from natural variation [20]. Without a unique foreign sequence, laboratories cannot design a confirmatory assay unless the developer discloses the edit. This limits the enforceability of any labeling rule for such products and caps the revenue laboratories can extract from them.

### Limited Accredited Laboratory Capacity

Countries newly approving biotech crops, including Nigeria [10], often have few laboratories holding ISO/IEC 17025 accreditation for GMO methods. Samples are shipped abroad, adding cost and turnaround time. Until domestic capacity matures, part of the regional demand is served by foreign laboratories or not tested at all.

### Deregulation of Precision-Bred Crops

England's Genetic Technology (Precision Breeding) Act 2023 removes qualifying gene-edited plants from GMO rules [16]. Similar exemptions in the United States reduce the number of products requiring event identification. As more traits move through these pathways, a slice of future development volume will bypass mandatory testing.

## Opportunities

## GMO Testing Market Opportunities

### Detection Methods for New Genomic Techniques

The European Commission's proposal on new genomic techniques would require traceability for certain edited plants, but the GMO testing market lacks routine methods for many of them. Laboratories that build sequencing-based reference libraries, partner with developers on disclosure-linked assays and secure validation through the European reference network [13] will own a premium niche. Early movers can license methods to smaller laboratories, creating a royalty stream alongside service revenue.

### Laboratory Build-Out in Africa and Southeast Asia

Nigeria and Kenya have approved biotech crops in the past three years [10][23], while Indonesia and Thailand are expanding import inspection. Joint ventures with national agencies, mobile laboratories and training contracts offer entry points with modest capital. A first-mover laboratory in these markets typically becomes the default reference for regulators, an advantage that compounds as volumes grow.

### Traceability Data Platforms and Subscription Testing

Test results carry value beyond the certificate. Laboratories can bundle sampling, testing and digital certificates into annual subscriptions for mid-sized food brands, and sell anonymized supply-chain risk dashboards that map GM presence by origin and season. Linking certificates to lot-level traceability systems lets buyers verify claims instantly, a service that commands higher margins than per-sample pricing.

### Field Biosensors at Elevators and Ports

Biosensor-based rapid tests deliver results within minutes at receiving points, letting elevators segregate loads before they mix. Pairing low-cost readers with cloud reporting turns a one-time kit sale into recurring consumables and data fees. The opportunity is largest in Brazil, Argentina and India, where receiving points greatly outnumber accredited laboratories.

### Outsourced Molecular Characterization for Seed Developers

Mid-sized seed companies and university spin-offs rarely maintain full regulatory laboratories. Contract providers offering sequencing, event-specific method development and dossier support under Codex criteria [14] can capture this work. Demand will rise as climate-resilient traits move from greenhouse to regulatory submission.

## Future Outlook

## GMO Testing Market Future Outlook

### New Genomic Techniques Reshape Detection Science

Gene editing is the single largest technical question facing the GMO testing market over the next decade. If Europe finalizes traceability rules for edited plants[12], laboratories will need reference sequences from developers and sequencing-based confirmation. Where edits are exempted, as in England [16], testing shifts toward documentary verification. Laboratories that can work in both regimes will hold an advantage.

### Automation, Digital PCR and Laboratory Informatics

Robotic extraction, high-density qPCR plates and digital PCR will lower cost per result and raise throughput. Laboratory information systems that auto-interpret amplification curves and flag anomalies will reduce analyst workload. Expect consolidation of smaller laboratories that cannot fund these upgrades into networks that can [19].

### Traceability and Data-Linked Certification

Certificates will increasingly travel with lots as digital records linked to traceability systems. Buyers will expect instant verification, and laboratories will monetize aggregated results as supply-chain risk intelligence. Such a model favors providers with dense sampling networks across origins.

### Climate-Resilient Crops and Rising Food Demand

World population is projected to approach 9.7 billion by 2050 [21], and breeders are responding with drought-, heat- and disease-tolerant traits. Every new trait passes through characterization, approval and market monitoring. As biotech adoption spreads to [wheat](https://www.marketresearchfuture.com/reports/wheat-market-41736), rice and potatoes, sample volumes will diversify beyond corn and soybean.

## Segment Insights

## GMO Testing Market Segmentation

### By Technology

Within the GMO testing market, Polymerase Chain Reaction (PCR) dominates because regulators validate event-specific PCR methods for authorization [13]. Immunoassay formats, including ELISA and Lateral Flow, serve rapid screening of raw commodities where proteins remain intact. Next-Generation Sequencing grows fastest as dossiers demand full insert characterization and unknown-event screening. Biosensor-based Rapid Tests fill the need for minutes-level results at receiving points.

| Segment | Key Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Polymerase Chain Reaction (PCR) | 58.9% share | Regulator-validated event-specific methods |
| Immunoassay (ELISA, Lateral Flow) | 25.4% share | Low-cost screening of raw grain |
| Next-Generation Sequencing | 6.7% CAGR (2026–2035) | Molecular characterization and unknown-event detection |
| Biosensor-based Rapid Tests | USD 0.31 Billion | On-site testing at elevators and plants |

### By Crop Type

Corn leads the GMO testing market by crop, reflecting the trade volume of stacked-trait hybrids. Canola is the fastest-growing crop as US harvested area rose 15% in 2024 [6]. Soybean testing remains substantial, Cotton testing serves fiber and seed supply chains, and Potato, Wheat and Rice are emerging as new GM varieties reach approval. Others covers specialty fruits and vegetables.

| Segment | Key Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Corn | 31.8% share | Stacked-trait hybrids in global trade |
| Soybean | USD 1.20 Billion | Export compliance and feed testing |
| Cotton | 11.2% share | Seed purity and cottonseed meal |
| Canola | 7.3% CAGR (2026–2035) | Acreage growth and export crushing |
| Potato | 5.9% CAGR (2026–2035) | Late-blight resistant varieties |
| Wheat | USD 0.16 Billion | HB4 wheat approvals |
| Rice | 4.8% share | Nutritionally enhanced varieties |
| Others | 6.0% CAGR (2026–2035) | Gene-edited specialty crops |

### By Application

Processed Food holds the largest application share of the GMO testing market because labeling rules apply at the finished-product level. [Animal Feed](https://www.marketresearchfuture.com/reports/animal-feed-market-1611) is the second-largest segment, driven by GM-free animal product labels. Seed Testing grows fastest on the strength of trait pipelines and purity requirements, while Others includes environmental monitoring and research use.

| Segment | Key Metric (2025) | Primary Demand Driver |
| --- | --- | --- |
| Processed Food | 48.3% share | Labeling and claim verification |
| Animal Feed | USD 1.15 Billion | GM-free livestock product labels |
| Seed Testing | 6.6% CAGR (2026–2035) | Trait pipelines and purity checks |
| Others | 7.7% share | Environmental monitoring and research |

## Regional Market Share Analysis

## Regional Market Share Analysis

| Region | Key Metric (2025) | Primary Investment Themes |
| --- | --- | --- |
| North America | USD 1.18 Billion | Disclosure-standard compliance, export certification, seed characterization |
| Europe | 34.5% share | 0.9% threshold enforcement, NGT detection, reference method validation |
| Asia-Pacific | 6.1% CAGR (2026–2035) | Import certificates, China commercialization, laboratory expansion |
| South America | 9.5% share | Export compliance, new trait approvals, elevator screening |
| Middle East and Africa | 6.9% CAGR (2026–2035) | New biotech approvals, import labeling, reference laboratory build-out |
| Total | USD 4.06 Billion | — |

Regional demand in the GMO testing market follows regulation more than crop production. Europe tests heavily despite planting few GM crops, while major producers in the Americas test mainly for export compliance.

### North America

| Country | Key Metric (2025) | Key Driver |
| --- | --- | --- |
| United States | 78.5% share of region | Disclosure standard and export certification |
| Canada | USD 0.13 Billion | Canola and soybean export testing |
| Mexico | 6.0% CAGR (2026–2035) | GM corn restrictions and import screening |
| Rest of North America | 2.1% share of region | Caribbean and Central American import checks |

The United States anchors the regional GMO testing market through the mandatory disclosure standard [4] and the world's largest export volume of GM soybean and corn [1]. Canola acreage reached more than 2.7 million harvested acres in 2024, up 15% from 2023 [6], adding samples for crushers serving export buyers. Mexico shows the fastest growth after its 2023 decree restricting GM corn for food, a USMCA panel ruling against those measures in December 2024 [17] and a March 2025 constitutional ban on GM corn planting [18], which together raise border testing of corn imports.

### Europe

| Country | Key Metric (2025) | Key Driver |
| --- | --- | --- |
| Germany | 21.4% share of region | GM-free retail labeling of animal products |
| United Kingdom | USD 0.17 Billion | Retailer audits and precision breeding framework |
| Italy | 5.0% CAGR (2026–2035) | National GM-free policies and food exports |
| France | 14.6% share of region | Strict feed and food controls |
| Spain | USD 0.10 Billion | Only significant EU cultivator of GM maize |
| Netherlands | 5.4% CAGR (2026–2035) | Port-of-entry testing at Rotterdam |
| Poland | 4.3% share of region | Imported soybean meal testing |
| Belgium | USD 0.05 Billion | Feed import controls via Antwerp |
| Sweden | 4.9% CAGR (2026–2035) | Organic sector verification |
| Rest of Europe | 15.2% share of region | Non-EU alignment with EU thresholds |

Europe's 0.9% labeling threshold [2] and strict traceability rules [3] make it the largest testing region despite limited cultivation. Germany leads, supported by its retail "Ohne Gentechnik" label covering feed for dairy, [meat](https://www.marketresearchfuture.com/reports/meat-market-68315) and eggs. France and Italy sustain demand through national GM-free policies, while Poland tests heavily on imported soybean meal. The European Parliament adopted its position on new genomic techniques in February 2024 [12], which could add a traceability layer requiring new detection methods.

### Asia-Pacific

| Country | Key Metric (2025) | Key Driver |
| --- | --- | --- |
| China | 34.2% share of region | Commercial GM planting and border controls |
| India | 7.4% CAGR (2026–2035) | Certificate requirement for imported crops |
| Japan | USD 0.17 Billion | Revised non-GMO claim rules |
| Australia | 7.8% share of region | Canola and cotton cultivation, 1% labeling |
| Indonesia | 6.9% CAGR (2026–2035) | Soybean import inspection |
| South Korea | USD 0.06 Billion | Corn and soybean import testing |
| Thailand | 3.9% share of region | Feed and food export certification |
| Singapore | 6.3% CAGR (2026–2035) | Regional laboratory hub services |
| Rest of Asia-Pacific | 9.6% share of region | Philippines and Vietnam biotech approvals |

China drives volume in the Asia-Pacific GMO testing market following its October 2023 approval of GM corn and soybean varieties for planting [9], which requires seed purity checks and segregation of approved events. India grows fastest as importers comply with the certificate rule for 24 crops [8]. Japan's 2023 revision limiting "non-GMO" claims to products with no detectable GM content [22] pushes importers toward more sensitive assays. Australia applies food standards that mandate labeling above 1%.

### South America

| Country | Key Metric (2025) | Key Driver |
| --- | --- | --- |
| Brazil | 52.6% share of region | Soybean and corn export compliance |
| Argentina | USD 0.10 Billion | HB4 wheat and export certification |
| Colombia | 6.4% CAGR (2026–2035) | Corn import testing |
| Chile | 6.1% share of region | Seed multiplication for export |
| Peru | 5.8% CAGR (2026–2035) | Cultivation moratorium enforcement |
| Rest of South America | 5.2% share of region | Paraguay and Bolivia soybean exports |

Brazil and Argentina rank among the world's largest biotech crop producers, and testing serves export markets in China and Europe. Brazil's biosafety commission approved cultivation of drought-tolerant HB4 wheat in 2023, extending testing into a crop that had previously been GM-free. Argentina developed HB4 wheat and tests extensively for buyers sensitive to unapproved events. Colombia, Chile and Peru apply import controls and segregation rules, with Peru maintaining a moratorium on GM cultivation.

### Middle East and Africa

| Country | Key Metric (2025) | Key Driver |
| --- | --- | --- |
| South Africa | 31.5% share of region | Established GM maize and soybean cultivation |
| Saudi Arabia | 7.8% CAGR (2026–2035) | Import labeling enforcement |
| United Arab Emirates | USD 0.02 Billion | Re-export hub food controls |
| Nigeria | 8.1% CAGR (2026–2035) | TELA maize and cowpea approvals |
| Egypt | 10.4% share of region | Grain and feed import testing |
| Morocco | 7.0% CAGR (2026–2035) | Feed import controls |
| Turkey | USD 0.03 Billion | Strict biosafety law enforcement |
| Rest of Middle East and Africa | 8.9% share of region | Kenya and Ghana program build-out |

South Africa has commercially grown GM crops since 1998 and holds the region's most developed laboratory base. Kenya's October 2022 decision to lift its GMO ban [23] and Nigeria's January 2024 approval of TELA maize [10] are building new national testing programs. Gulf importers, led by Saudi Arabia and the United Arab Emirates, enforce labeling on imported food, while Turkey operates one of the region's strictest biosafety regimes. Egypt and Morocco test large volumes of imported grain and feed.

## Competitive Benchmarking

## Competitive Benchmarking

The GMO testing market shows medium concentration, with an estimated HHI of 800–1,000 and the top five providers holding roughly 33–40% of revenue. Global laboratory networks dominate regulated trade lanes, while specialist kit makers and national laboratories serve local demand. Most GMO work is sold inside broader food safety testing contracts, which favors providers with full-service portfolios and multi-country accreditation [24].

| Company | Est. Revenue Share Range | Key Offerings for gmo testing market | Strategic Positioning |
| --- | --- | --- | --- |
| Eurofins Scientific SE | ~11–14% | Event-specific qPCR, sequencing, seed characterization | Largest network; acquisition-led expansion |
| SGS SA | ~7–9% | Food and feed screening, certification | Inspection-led integrated services |
| Intertek Group plc | ~5–7% | Food testing, supply-chain assurance | Assurance bundled with audits |
| Bureau Veritas SA | ~4–6% | Commodity inspection and testing | Strength at ports and trade lanes |
| ALS Limited | ~3–5% | Food and agricultural testing | Strong in Asia-Pacific and Americas |
| Mérieux NutriSciences Corp. | ~3–5% | Food safety and GMO analysis | Consulting-linked services |
| Cotecna Group | ~1–3% | Grain inspection and testing | Emerging-market inspection focus |
| Neogen Corporation | ~2–4% | Lateral flow and ELISA kits | Rapid-test leadership |
| Thermo Fisher Scientific Inc. | ~2–4% | qPCR instruments and reagents | Platform supplier to laboratories |
| Bio-Rad Laboratories, Inc. | ~2–3% | Digital PCR systems | Precision quantification niche |
| LGC Limited | ~2–3% | Reference materials, automated PCR | Standards and high-throughput genotyping |
| Romer Labs | ~1–2% | Rapid strip tests | Field and elevator screening |

## Recent News & Developments

## Recent News & Developments

Recent regulatory and corporate events show how the GMO testing market is being shaped by policy on both edited and conventional GM crops.

- UK Parliament (March 2023): The Genetic Technology (Precision Breeding) Act received Royal Assent, creating a separate pathway for qualifying gene-edited plants in England [16]
- China Ministry of Agriculture and Rural Affairs (October 2023): Approved additional GM corn and soybean varieties, expanding the need for seed purity and segregation testing [9]
- Nigeria National Biotechnology Management Agency (January 2024): Approved TELA maize for commercial release, adding a new national testing program [10]
- European Parliament (February 2024): Adopted its position on new genomic technique plants, shaping future traceability and detection requirements [12]
- International Conference on GMO Analysis and NGTs (March 2024): Laboratory experts highlighted the need for enhanced methods to detect new genomic technique products [25]
- Eurofins Scientific (October 2024): Reported EUR 5.142 billion nine-month revenue alongside its planned acquisition of SGS crop science activities [19]
- USMCA Dispute Panel (December 2024): Ruled Mexico's GM corn measures were not based on science, influencing import testing protocols [17]
- Government of Mexico (March 2025): Enacted a constitutional amendment banning GM corn cultivation, sustaining border testing demand [18]

## Report Scope

| Parameter | Details |
| --- | --- |
| Market Scope | The GMO testing market covers PCR, immunoassay, sequencing and biosensor-based testing of crops, processed food, animal feed and seed. |
| Study Period | 2021–2035 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2035 |
| Market Size in 2025 | USD 4.06 Billion |
| Market Size in 2035 | USD 6.91 Billion |
| CAGR (2026–2035) | 5.5% |
| Fastest Growing Segments | Canola (7.3% CAGR); Next-Generation Sequencing (6.7% CAGR); Seed Testing (6.6% CAGR) |
| Regions Covered | North America, Europe, South America, Asia Pacific, Middle East and Africa and ROW |
| Companies Profiled | Eurofins Scientific SE, SGS SA, Intertek Group plc, Bureau Veritas SA, ALS Limited, Mérieux NutriSciences Corp., Cotecna Group, Neogen Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Romer Labs |
| Valuation Currency | USD Billion |
| Methodology | 350+ primary expert interviews; bottom-up market sizing; top-down validation; data triangulation; scenario-based forecasting; real-time project tracking |

## Frequently Asked Questions

**Q: How does gene editing change what the GMO testing market can actually detect?**
A: Edits made with SDN-1 techniques often leave no foreign DNA, so a point mutation can look identical to natural variation [20]. Laboratories can confirm a known edit with a validated assay, but cannot reliably flag an unknown one without reference sequences.

**Q: What accreditation should buyers require from a GMO testing laboratory?**
A: Ask for ISO/IEC 17025 accreditation whose scope explicitly lists the ISO 21569, 21570 and 21571 detection, quantification and extraction methods. Recent satisfactory proficiency-test scores for the specific events you trade matter more than a general certificate.

**Q: Why is sampling often the largest source of error in GMO results?**
A: GM kernels are rarely spread evenly through a bulk lot, so a poorly drawn sample can misstate content far more than any assay error. ISO 24333 sets probe patterns and increment counts for grain lots, and buyers should specify it contractually.

**Q: How did Japan's 2023 labeling revision affect testing demand?**
A: Since April 2023, Japan permits a "non-GMO" claim only when GM content is not detected, replacing the earlier tolerance of up to 5% [22]. Importers of soybean and corn ingredients now order more sensitive quantitative assays to defend that claim.

**Q: Are lateral flow strips adequate for export compliance?**
A: Rarely. Strips confirm whether a target protein is present, but they cannot quantify against legal thresholds, and processing destroys proteins in refined ingredients. Most importing authorities accept only DNA-based quantitative results for certificates.

**Q: What makes the GMO testing market attractive to acquirers?**
A: Validated method portfolios and accreditations take years to build, which gives incumbents durable pricing power. Volumes are tied to statutory labeling and import rules rather than discretionary budgets, so revenue stays steady through commodity cycles.

**Q: How does digital PCR compare with real-time PCR for quantification in the GMO testing market?**
A: Digital PCR partitions a sample into thousands of reactions, giving absolute copy counts without calibration curves and better precision near low thresholds. Real-time PCR remains cheaper per sample and faster to run, so the GMO testing market uses digital platforms mainly for confirmation and disputes.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gmo-testing-market-32843*